Cryptocurrencies

Genesis’s $4.2B Move: Bitcoin Buys & GBTC Sales Amid Debt

Quick Look:

  • Genesis acquires 32,041 Bitcoins for $2.1 billion, aimed at debt settlement.
  • Sold 36 million GBTC shares for $2.1 billion, enhancing liquidity.
  • Opposition from DCG in bankruptcy proceedings highlights plan complexities.
  • Strategic moves align with the upcoming Bitcoin halving event on April 19.
  • Efforts are part of a broader strategy to revitalize financial standing amid $3.5 billion debt.

Genesis, a leading cryptocurrency lender, has embarked on a strategic plan involving substantial Bitcoin acquisitions and sales of its GBTC shares. This plan is part of the company’s broader strategy to settle debts and revitalize its financial standing.

$2.1B Bitcoin Buy: Genesis’s Debt Settlement Strategy

Genesis has acquired an impressive 32,041 Bitcoins (BTC) at a purchase price of $65,685 per BTC. Therefore totalling an investment of $2.1 billion. This acquisition is primarily aimed at debt settlement. With a significant portion of the acquired Bitcoin slated for distribution among creditors. Notably enrollees of the Gemini Earn program.

This move comes at a critical juncture, with the company grappling with a daunting $3.5 billion debt. The current market price of Bitcoin stands at $67,500, slightly above the purchase price. Thereby valuing Genesis’s Bitcoin holdings at approximately $2.2 billion. With Bitcoin’s price showing a notable increase of 2.55% in the last day to $69,339, the timing appears strategic, especially with the anticipated Bitcoin halving event on April 19. This event is expected to halve mining rewards from 6.25 BTC to 3.125 BTC, potentially influencing Bitcoin’s price dynamics.

$2.1B from GBTC Sales: Genesis’s Liquidity Boost

On another front, Genesis completed the sale of 36 million GBTC shares on April 2, with the sale price per share marked at $58.50, up from an initial value of $38.50. This sale has generated $2.1 billion, matching the investment in Bitcoin and marking a significant step towards liquidity enhancement.

The sale of GBTC shares received the green light from the New York bankruptcy court on February 15, with permission granted to sell not just GBTC shares but also additional shares in Grayscale Ethereum Trusts. This move was essential for Genesis to proceed with its bankruptcy plan, which involves converting GBTC shares to Bitcoin or cash for debt settlement.

Genesis vs DCG: Bankruptcy Plan Battles

Genesis’s bankruptcy filing in January 2023 outlined a contentious plan that Digital Currency Group (DCG) opposed. Moreover, it claims it violates the Bankruptcy Code by unfairly favouring senior creditors. After that, this opposition highlights the complexities of navigating bankruptcy proceedings in the rapidly evolving crypto landscape.

Furthermore, Genesis’s journey through bankruptcy is marked by its attempt to manage the fallout from the FTX collapse and its impact on the crypto market. With a pre-bankruptcy filing claim of no imminent bankruptcy plans, the post-FTX collapse saw the company suspending customer redemptions and seeking an emergency loan of $1 billion, as the Wall Street Journal reported.

Financial Gambit: A Path to Recovery?

Genesis’s strategic acquisitions and sales underscore the company’s efforts to navigate its financial difficulties and emerge stronger. With the cryptocurrency market notoriously volatile, the outcome of Genesis’s strategy remains to be seen. However, these moves highlight the company’s commitment to addressing its debt obligations and stabilizing its operations amidst challenging times. Investors and stakeholders will closely watch Genesis’s financial manoeuvres as the market eyes the upcoming Bitcoin halving.

Share
Published by
Chloe Wilson

Recent Posts

  • Education

Cryptocurrency Taxation: A Comprehensive Guide

The evolution of digital finance has ushered in the era of cryptocurrencies, which the IRS… Read More

19 hours ago
  • Stock Markets

Summit Therapeutics Targets $3.73B Cap in Oncology Drive

Quick Look: Summit Therapeutics's key drug in advanced trials for lung cancer, leveraging dual pathway… Read More

20 hours ago
  • Commodities

Sugar Price Fluctuates 2.4% Amid Global Production Shifts

Quick Look: NY's Sugar and London's White Sugar contracts saw similar rises by about 2.40%.… Read More

20 hours ago
  • Technology

HMD Global Shifts Nokia Production to Europe, Targets 5G

Quick Look: HMD Global shifts Nokia's production to Europe, focusing on 5G tech. New Nokia… Read More

21 hours ago
  • Cryptocurrencies

LocalMonero to Close: A Blow to the No-KYC Monero Ecosystem

Quick Look: LocalMonero is set to close by November 7, 2024, due to undisclosed factors… Read More

23 hours ago
  • Cryptocurrencies

Robinhood Challenges SEC’s Claim on Crypto Trading

Quick Look: Robinhood received a Wells notice from the SEC on May 4, 2023, regarding… Read More

23 hours ago